Literature DB >> 22772598

Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases.

Marco M Ciccone1, Pietro Scicchitano, Michele Gesualdo, Annapaola Zito, Rosa Carbonara, Manuela Locorotondo, Cosimo Mandurino, Filippo Masi, Francesca Boccalini, Mario E Lepera.   

Abstract

AIMS: Osteoprotegerin (OPG) plays a key role in atherosclerosis progression and plaque destabilization. We investigated the relationship between intima-media thickness of the common carotid artery (CCA-IMT; an early marker of atherosclerosis) and OPG levels in patients with acute coronary syndrome (ACS) and chronic coronary artery disease (CAD).
METHODS: We studied 133 consecutive patients, mean age 65 ± 9 years, referred to our department for coronary angiography. They were evaluated for cardiovascular risk factors, OPG levels and CCA-IMT and accordingly divided in two subgroups: ACS and chronic CAD.
RESULTS: Except for age, the two groups were similar according to conventional cardiovascular risk factors. The chronic CAD group showed a CCA-IMT lower than the ACS group (0.86 ± 0.15 vs. 0.94 ± 0.22 mm, P = 0.027); there were no differences regarding the extension of coronary atherosclerosis on angiograms. The OPG levels were higher in chronic CAD patients than in ACS patients (5.36 ± 3.06 vs. 3.85 ± 2.96 pmol/l, P = 0.004). Moreover, the CCA-IMT was significantly correlated with the age of the patients (r = 0.5; P < 0.001). OPG values were not related either to age or to the CCA-IMT. At analysis of covariance, when adjusting the groups for age, the comparison of the two groups lost statistical significance for CCA-IMT (P = 0.41), whereas the OPG values remained significant after the correction (P = 0.001).
CONCLUSION: OPG levels are higher in chronic CAD patients. CCA-IMT confirmed its importance in predicting CAD, showing significantly higher values in the patients in the ACS group as compared with those in the chronic CAD group.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22772598     DOI: 10.2459/JCM.0b013e3283561433

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  5 in total

1.  Association of circulating sclerostin with vascular calcification in Afro-Caribbean men.

Authors:  Allison L Kuipers; Iva Miljkovic; J Jeffery Carr; James G Terry; Cara S Nestlerode; Yaorong Ge; Clareann H Bunker; Alan L Patrick; Joseph M Zmuda
Journal:  Atherosclerosis       Date:  2015-01-17       Impact factor: 5.162

Review 2.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

Review 3.  A novel cardiac bio-marker: ST2: a review.

Authors:  Marco Matteo Ciccone; Francesca Cortese; Michele Gesualdo; Roberta Riccardi; Dalia Di Nunzio; Michele Moncelli; Massimo Iacoviello; Pietro Scicchitano
Journal:  Molecules       Date:  2013-12-11       Impact factor: 4.411

4.  Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni; Stella Douma; Georgios Efstratiadis; Dimitrios Memmos
Journal:  BMC Nephrol       Date:  2013-06-12       Impact factor: 2.388

5.  Stenosis level, plaque morphology and intima-media thickness of internal carotid artery in chronic stable angina and acute coronary syndrome; a comparative study.

Authors:  Gholam Abbas Valizadeh; Saeede Zareie; Alireza Manafi; Kamran Nikfarjam
Journal:  Iran Red Crescent Med J       Date:  2015-01-20       Impact factor: 0.611

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.